Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

Kerr, Keith
Bibeau, Frédéric
Thunnissen, Erik
Botling, Johan
Ryška, Aleš
Wolf, Jürgen
Öhrling, Katarina
Burdon, Peter
Malapelle, Umberto
Büttner, Reinhard

Publication date

December 2021

DOI

10.1016/j.lungcan.2021.02.026

Publisher

Elsevier BV

Journal

Lung Cancer

Language

English

Abstract

Funding Supported by Amgen (Europe) GmbH (Rotkreuz, Switzerland).Peer reviewedPublisher PD

Extracted data

Related items

NSCLC molecular testing in Central and Eastern European countries

Ryska A
Berzinec P
Brcic L
Cufer T
Dziadziuszko R
Gottfried M
Kovalszky, Ilona
Olszewski W
Oz B
Plank L
Tímár, József

July 2018

Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC...

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

Broek, D. van den
Hiltermann, T.J.N.
Biesma, B.
Dinjens, W.N.
Hart, N.A. t
Hinrichs, J.W.
Leers, M.P.G.
Monkhorst, K.
Oosterhout, M. van
Scharnhorst, V.
Schuuring, E.
Speel, E.M.
Heuvel, M. van den
Schaik, R.H. van
Thusen, J. von der
Willems, S.M.
Visser, L de
Ligtenberg, M.J.L.

January 2019

Contains fulltext : 218328.pdf (publisher's version ) (Open Access)The diagnostic ...

Updated Guidelines for Predictive Biomarker Testing in Advanced Non-Small-Cell Lung Cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Garrido, P.
Conde, E.
Castro, J. de
Gómez Román, José Javier
Felip, E.
Pijuan, L.
Isla, D.
Sanz, J.
Paz Ares, L.
López Ríos, F.

January 2020

In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) s...

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

Kerr, Keith M.
Bibeau, Frederic
Thunnissen, Erik
Botling, Johan
Ryska, Ales
Wolf, Jurgen
Ohrling, Katarina
Burdon, Peter
Malapelle, Umberto
Buttner, Reinhard

January 2021

The discovery of oncogenic driver mutations rendering non-small cell lung cancer (NSCLC) targetable ...

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Griesinger, Frank
Eberhardt, Wilfried E. E.
Nusch, Arnd
Reiser, Marcel
Zahn, Mark-Oliver
Maintz, Christoph
Bernhardt, Christiane
Losem, Christoph
Stenzinger, Albrecht
Heukamp, Lukas
Büttner, Reinhard
Marschner, Sebastian
Jänicke, Martina
Fleitz, Annette
Spring, Lisa
Sahlmann, Jörg
Karatas, Aysun
Hipper, Annette
Weichert, Wilko
Heilmann, Monika
Sadjadian, Parvis
Gleiber, Wolfgang
Grah, Christian
Waller, Cornelius
Reck, Martin
Rittmeyer, Achim
Christopoulos, Petros
Sebastian, Martin
Thomas, Michael

November 2020

Objectives: An increasing number of treatment-determining biomarkers has been identified in non-smal...

Biomarker Testing for People With Advanced Lung Cancer in England

Adizie, JB
Tweedie, J
Khakwani, A
Peach, E
Hubbard, R
Wood, N
Gosney, JR
Harden, SV
Beckett, P
Popat, S
Navani, N

June 2021

Introduction: Optimal management of people with advanced NSCLC depends on accurate identification of...

Biomarker testing for people with advanced lung cancer in England

Adizie, JB
Tweedie, J
Khakwani, A
Peach, E
Hubbard, R
Wood, N
Gosney, JR
Harden, SV
Beckett, P
Popat, S
Navani, N

April 2021

Introduction: Optimal management of people with advanced NSCLC depends on accurate identification of...

Lung cancer biomarker testing : perspective from Europe

Thunnissen, Erik
Weynand, Birgit
Udovicic-Gagula, Dalma
Brcic, Luka
Szolkowska, Malgorzata
Hofman, Paul
Smojver-Jezek, Silvana
Anttila, Sisko
Calabrese, Fiorella
Kern, Izidor
Skov, Birgit
Perner, Sven
Dale, Vibeke G.
Eri, Zivka
Haragan, Alex
Leonte, Diana
Carvallo, Lina
Prince, Spasenja Savic
Nicholson, Siobhan
Sansano, Irene
Ryska, Ales

June 2020

A questionnaire on biomarker testing previously used in central European countries was extended and ...

Mutation-tailored treatment selection in non-small cell lung cancer patients in daily clinical practice

Steeghs, Elisabeth M.P.
Groen, Harry J.M.
Schuuring, Ed
Aarts, Mieke J.
Damhuis, Ronald A.M.
Voorham, Quirinus J.M.
Ligtenberg, Marjolijn J.L.
Grünberg, Katrien

May 2022

Objectives: The number of targeted drugs in non-small cell lung cancer (NSCLC) is ever-expanding and...

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands:How to Deal With Increasing Complexity

van den Broek, Daan
Hiltermann, T. Jeroen N.
Biesma, Bonne
Dinjens, Winand N. M.
't Hart, Nils A.
Hinrichs, John W. J.
Leers, Mathie P. G.
Monkhorst, Kim
van Oosterhout, Matthijs
Scharnhorst, Volkher
Schuuring, Ed
Speel, Ernst-Jan M.
van den Heuvel, Michel M.
van Schaik, Ron H. N.
von der Thusen, Jan
Willems, Stefan M.
de Visser, Leonie
Ligtenberg, Marjolijn J. L.

January 2020

The diagnostic landscape of non-small cell lung cancer (NSCLC) is changing rapidly with the availabi...

NSCLC molecular testing in Central and Eastern European countries

Ryska A
Berzinec P
Brcic L
Cufer T
Dziadziuszko R
Gottfried M
Kovalszky, Ilona
Olszewski W
Oz B
Plank L
Tímár, József

July 2018

Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC...

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

Broek, D. van den
Hiltermann, T.J.N.
Biesma, B.
Dinjens, W.N.
Hart, N.A. t
Hinrichs, J.W.
Leers, M.P.G.
Monkhorst, K.
Oosterhout, M. van
Scharnhorst, V.
Schuuring, E.
Speel, E.M.
Heuvel, M. van den
Schaik, R.H. van
Thusen, J. von der
Willems, S.M.
Visser, L de
Ligtenberg, M.J.L.

January 2019

Contains fulltext : 218328.pdf (publisher's version ) (Open Access)The diagnostic ...

Updated Guidelines for Predictive Biomarker Testing in Advanced Non-Small-Cell Lung Cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Garrido, P.
Conde, E.
Castro, J. de
Gómez Román, José Javier
Felip, E.
Pijuan, L.
Isla, D.
Sanz, J.
Paz Ares, L.
López Ríos, F.

January 2020

In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) s...

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

Kerr, Keith M.
Bibeau, Frederic
Thunnissen, Erik
Botling, Johan
Ryska, Ales
Wolf, Jurgen
Ohrling, Katarina
Burdon, Peter
Malapelle, Umberto
Buttner, Reinhard

January 2021

The discovery of oncogenic driver mutations rendering non-small cell lung cancer (NSCLC) targetable ...

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Griesinger, Frank
Eberhardt, Wilfried E. E.
Nusch, Arnd
Reiser, Marcel
Zahn, Mark-Oliver
Maintz, Christoph
Bernhardt, Christiane
Losem, Christoph
Stenzinger, Albrecht
Heukamp, Lukas
Büttner, Reinhard
Marschner, Sebastian
Jänicke, Martina
Fleitz, Annette
Spring, Lisa
Sahlmann, Jörg
Karatas, Aysun
Hipper, Annette
Weichert, Wilko
Heilmann, Monika
Sadjadian, Parvis
Gleiber, Wolfgang
Grah, Christian
Waller, Cornelius
Reck, Martin
Rittmeyer, Achim
Christopoulos, Petros
Sebastian, Martin
Thomas, Michael

November 2020

Objectives: An increasing number of treatment-determining biomarkers has been identified in non-smal...

Biomarker Testing for People With Advanced Lung Cancer in England

Adizie, JB
Tweedie, J
Khakwani, A
Peach, E
Hubbard, R
Wood, N
Gosney, JR
Harden, SV
Beckett, P
Popat, S
Navani, N

June 2021

Introduction: Optimal management of people with advanced NSCLC depends on accurate identification of...

Biomarker testing for people with advanced lung cancer in England

Adizie, JB
Tweedie, J
Khakwani, A
Peach, E
Hubbard, R
Wood, N
Gosney, JR
Harden, SV
Beckett, P
Popat, S
Navani, N

April 2021

Introduction: Optimal management of people with advanced NSCLC depends on accurate identification of...

Lung cancer biomarker testing : perspective from Europe

Thunnissen, Erik
Weynand, Birgit
Udovicic-Gagula, Dalma
Brcic, Luka
Szolkowska, Malgorzata
Hofman, Paul
Smojver-Jezek, Silvana
Anttila, Sisko
Calabrese, Fiorella
Kern, Izidor
Skov, Birgit
Perner, Sven
Dale, Vibeke G.
Eri, Zivka
Haragan, Alex
Leonte, Diana
Carvallo, Lina
Prince, Spasenja Savic
Nicholson, Siobhan
Sansano, Irene
Ryska, Ales

June 2020

A questionnaire on biomarker testing previously used in central European countries was extended and ...

Mutation-tailored treatment selection in non-small cell lung cancer patients in daily clinical practice

Steeghs, Elisabeth M.P.
Groen, Harry J.M.
Schuuring, Ed
Aarts, Mieke J.
Damhuis, Ronald A.M.
Voorham, Quirinus J.M.
Ligtenberg, Marjolijn J.L.
Grünberg, Katrien

May 2022

Objectives: The number of targeted drugs in non-small cell lung cancer (NSCLC) is ever-expanding and...

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands:How to Deal With Increasing Complexity

van den Broek, Daan
Hiltermann, T. Jeroen N.
Biesma, Bonne
Dinjens, Winand N. M.
't Hart, Nils A.
Hinrichs, John W. J.
Leers, Mathie P. G.
Monkhorst, Kim
van Oosterhout, Matthijs
Scharnhorst, Volkher
Schuuring, Ed
Speel, Ernst-Jan M.
van den Heuvel, Michel M.
van Schaik, Ron H. N.
von der Thusen, Jan
Willems, Stefan M.
de Visser, Leonie
Ligtenberg, Marjolijn J. L.

January 2020

The diagnostic landscape of non-small cell lung cancer (NSCLC) is changing rapidly with the availabi...

NSCLC molecular testing in Central and Eastern European countries

Ryska A
Berzinec P
Brcic L
Cufer T
Dziadziuszko R
Gottfried M
Kovalszky, Ilona
Olszewski W
Oz B
Plank L
Tímár, József

July 2018

Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC...

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

Broek, D. van den
Hiltermann, T.J.N.
Biesma, B.
Dinjens, W.N.
Hart, N.A. t
Hinrichs, J.W.
Leers, M.P.G.
Monkhorst, K.
Oosterhout, M. van
Scharnhorst, V.
Schuuring, E.
Speel, E.M.
Heuvel, M. van den
Schaik, R.H. van
Thusen, J. von der
Willems, S.M.
Visser, L de
Ligtenberg, M.J.L.

January 2019

Contains fulltext : 218328.pdf (publisher's version ) (Open Access)The diagnostic ...

Updated Guidelines for Predictive Biomarker Testing in Advanced Non-Small-Cell Lung Cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Garrido, P.
Conde, E.
Castro, J. de
Gómez Román, José Javier
Felip, E.
Pijuan, L.
Isla, D.
Sanz, J.
Paz Ares, L.
López Ríos, F.

January 2020

In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) s...